Covered recipient · General Payments record
NICOLE A BELL
Allopathic & Osteopathic Physicians Obstetrics & Gynecology
General Payments · PY2018–2024
$4,480.25
- Reported across 213 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $295.04 | 16 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Organon LLC | $80.30 | 5 |
| Biogen, Inc. | $49.17 | 2 |
| Daiichi Sankyo Inc. | $46.55 | 2 |
| Astellas Pharma US Inc | $36.99 | 2 |
| Evofem Biosciences, Inc. | $21.04 | 1 |
| CooperSurgical, Inc. | $20.64 | 1 |
| Exeltis, USA Inc. | $17.38 | 1 |
| Sumitomo Pharma America, Inc. | $14.63 | 1 |
| MAYNE PHARMA COMMERCIAL LLC | $8.34 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Astellas Pharma US Inc | $18.65 | 02/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139316302 | CMS |
| Astellas Pharma US Inc | $18.34 | 06/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139360607 | CMS |
| Biogen, Inc. | $20.79 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104836091 | CMS |
| Biogen, Inc. | $28.38 | 06/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104866284 | CMS |
| CooperSurgical, Inc. | $20.64 | 06/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150798353 | CMS |
| Daiichi Sankyo Inc. | $26.68 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089398939 | CMS |
| Daiichi Sankyo Inc. | $19.87 | 06/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089398947 | CMS |
| Evofem Biosciences, Inc. | $21.04 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1091270911 | CMS |
| Exeltis, USA Inc. | $17.38 | 03/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1149986497 | CMS |
| MAYNE PHARMA COMMERCIAL LLC | $8.34 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154687081 | CMS |
| Organon Llc | $22.61 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136296116 | CMS |
| Organon Llc | $0.70 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136296118 | CMS |
| Organon Llc | $17.34 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136296120 | CMS |
| Organon Llc | $19.34 | 06/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136296122 | CMS |
| Organon Llc | $20.31 | 07/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136296114 | CMS |
| Sumitomo Pharma America, Inc. | $14.63 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148826408 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.